AUXILIUM PHARMACEUTICALS INC Share-based Payment Arrangement, Expense
AUXILIUM PHARMACEUTICALS INC reported Share-based Payment Arrangement, Expense of $3.40 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-10-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2014-10-30
- AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2014-09-30 was $3.40M, a 0.86% increase year-over-year.
- AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2014-06-30 was $5.11M, a 21.20% increase year-over-year.
- AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2014-03-31 was $4.12M, a 9.68% increase year-over-year.
- AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2013-12-31 was $4.18M, a 7.21% increase year-over-year.
- AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2013 was $15.52M, a 3.43% increase from fiscal 2012.
- AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2012 was $15.01M, a 13.14% decline from fiscal 2011.
- AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2011 was $17.28M, a 3.81% decline from fiscal 2010.
- AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2010 was $17.96M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2014-09-30 | $3.40M 10-Q · filed 2014-10-30 | $8.51M derived: sum of 2 quarters · filed 2014-10-30 | $12.63M 10-Q · filed 2014-10-30 | $16.81M derived: sum of 4 quarters · filed 2014-10-30 |
| 2014-06-30 | $5.11M 10-Q · filed 2014-08-07 | $9.23M 10-Q · filed 2014-08-07 | $13.41M derived: sum of 3 quarters · filed 2014-08-07 | $16.78M derived: sum of 4 quarters · filed 2014-10-30 |
| 2014-03-31 | $4.12M 10-Q · filed 2014-05-05 | $8.30M derived: sum of 2 quarters · filed 2014-05-05 | $11.67M derived: sum of 3 quarters · filed 2014-10-30 | $15.89M derived: sum of 4 quarters · filed 2014-10-30 |
| 2013-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $7.55M derived: sum of 2 quarters · filed 2014-10-30 | $11.76M derived: sum of 3 quarters · filed 2014-10-30 | $15.52M 10-K · filed 2014-02-28 |
| 2013-09-30 | $3.37M 10-Q · filed 2014-10-30 | $7.59M derived: sum of 2 quarters · filed 2014-10-30 | $11.35M 10-Q · filed 2014-10-30 | $15.24M derived: sum of 4 quarters · filed 2014-10-30 |
| 2013-06-30 | $4.22M 10-Q · filed 2014-08-07 | $7.98M 10-Q · filed 2014-08-07 | $11.87M derived: sum of 3 quarters · filed 2014-08-07 | $15.41M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $3.76M 10-Q · filed 2014-05-05 | $7.65M derived: sum of 2 quarters · filed 2014-05-05 | $11.19M derived: sum of 3 quarters · filed 2014-05-05 | $15.09M derived: sum of 4 quarters · filed 2014-05-05 |
| 2012-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $7.43M derived: sum of 2 quarters · filed 2014-02-28 | $11.33M derived: sum of 3 quarters · filed 2014-02-28 | $15.01M 10-K · filed 2014-02-28 |
| 2012-09-30 | $3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $7.43M derived: sum of 2 quarters · filed 2013-11-06 | $11.11M 10-Q · filed 2013-11-06 | $16.25M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $3.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $7.57M 10-Q · filed 2013-08-01 | $12.71M derived: sum of 3 quarters · filed 2014-02-28 | $16.55M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $3.68M 10-Q · filed 2013-04-30 | $8.82M derived: sum of 2 quarters · filed 2014-02-28 | $12.66M derived: sum of 3 quarters · filed 2014-02-28 | |
| 2011-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $8.98M derived: sum of 2 quarters · filed 2014-02-28 | $17.28M 10-K · filed 2014-02-28 | |
| 2011-09-30 | $3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $12.14M 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $8.30M 10-Q · filed 2012-07-31 | |||
| 2010-12-31 | $17.96M 10-K · filed 2013-02-26 |